Lauren Quinlan
Publications by Year
Research Areas
Genetic and Kidney Cyst Diseases, Schizophrenia research and treatment, Neurotransmitter Receptor Influence on Behavior, Parkinson's Disease Mechanisms and Treatments, Multiple Sclerosis Research Studies
Most-Cited Works
- → A Model‐Informed Drug Development Approach Supporting the Approval of an Unstudied Valbenazine Dose for Patients With Tardive Dyskinesia(2024)2 cited
- → Development of a Population Pharmacokinetic Model for the Diroximel Fumarate Metabolites Monomethyl Fumarate and 2-Hydroxyethyl Succinimide Following Oral Administration of Diroximel Fumarate in Healthy Participants and Patients with Multiple Sclerosis(2022)2 cited
- → Development of a Clinical Trial Enrichment (CTE) Tool for Autosomal Dominant Polycystic Kidney Disease(2023)
- → Modeling Huntington’s disease progression utilizing the Huntington’s disease integrated staging system(2026)
- → A Single and Repeat-Dose Study of RZ358 in Patients With Post-Gastric Bypass Hypoglycemia (PGBH): Results of Population Pharmacokinetic (PK) / Pharmacodynamic (PD) Modeling(2021)
- → A time-to-event model for Bronchopulmonary dysplasia based on real-world data(2024)
- → Disease progression model for TKV and eGFR prediction in patients with autosomal dominant polycystic kidney disease(2026)
- → An R-based workflow for clinical trial simulation tool with application in type 1 diabetes studies(2024)
- → Challenges in curating Real World Data for modeling: A Bronchopulmonary Dysplasia case study(2025)